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Secondhand aerosol exposure during mechanical
ventilation with and without expiratory filters: An
in-vitro study
Arzu Ari, James B Fink, Sue Pilbeam
Email: arzuari@hotmail.com

Abstract
Background: Concerns have been expressed about risk of exposure to exhaled aerosols to ICU personnel.
AIM: To quantify amount of aerosol collected at the exhaust outlet of mechanical ventilators operated with
and without filters in the expiratory limb. Methods: Two categories of ventilators were tested: (1) Ventilators
without Proprietary Filters: Servo-i (Maquet) and Galileo (Hamilton) and (2) Ventilator with proprietary filters:
PB 840 (Covidien). Each ventilator was attached to a simple test lung and operated with VT 500 ml, RR 20
bpm, PIF 50 L/min, PEEP 5 cmH2O. Four separate doses of albuterol (2.5 mg/3mL) were administered via
jet nebuliser (eValueMed, Tri-anim) placed at the “Y”. In Experiment A, a filter (Respirgard 303) was placed
at the exhaust port. In Experiment B, two filters were attached to the ventilators without proprietary filters:
(1) at the end of expiratory limb and (2) at the exhaust outlet. Drug was eluted from filters and measured
using spectrophotometry. Results: Drug deposited at the exhaust port without expiratory filtering was >160
fold higher than with expiratory filtering. The collecting filter used in this study was less efficient than the
proprietary filter designed for use with the ventilator. Regardless of type of filter used, placement of filter in the
expiratory limb reduced secondhand aerosol exposure significantly. Conclusion: Risk of secondhand exposure
to exhaled aerosol can account for >45% of nominal dose as well as droplet nuclei produced by patients. Using
expiratory filters decreases risk of exposure to aerosol released to the atmosphere during mechanical ventilation.
Keywords: Aerosols, mechanical ventilation, secondhand aerosol exposure, and inhalation therapy.

Introduction
While many studies have quantified delivery of
medical aerosols to the lungs of mechanically
ventilated patients, less is known about the fate of
aerosols which are exhaled by the patient and those
aerosols which bypass the patient completely. Both
types of aerosol entering the ambient environment
may result in ‘secondhand exposure’ and provide cause
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for concern. Second hand exposure to medication
intended for inhalation may have deleterious
impact on care providers, visitors and other
patients in the vicinity. For example, secondhand
exposure to inhaled bronchodilators by health care
professionals has been associated with development
of occupational asthma.1-14 Respiratory therapists
have an increased risk of developing asthma after
entering the profession.15,16 That may be explained
in part by their work environment as they are
responsible for patient care with inhaled medications,
routine monitoring of patients, equipment cleaning
and maintenance that may cause exposure to a range
of aerosolised substances in the hospital setting.
Some studies show that there is an economic impact
of respiratory-related work disability due to work
loss and reported that better control of workplace
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exposure may reduce work disability caused by
respiratory conditions.12,17-19
We know that patients while coughing, talking and
even laughing can generate aerosols as droplet nuclei
capable of transmitting bacteria and viral vectors.
Exhaled particles from intubated patients are likely to
have mass median aerodynamic diameters (MMAD)
of less than 2 µm, as no particles of a greater
diameter than that have been observed exiting
endotracheal tubes. Particles in this range tend to
not deposit via inertial impaction or sedimentation,
and are capable of remaining suspended in the air
for extended periods of time. For infectious agents,
where low concentration exposure is sufficient for
transmission, exhaled patient generated aerosols
may pose the most ominous risks. Exhaled particles
from patients with pulmonary tuberculosis (TB)
have been documented to infect other patients
between wards and separate health care facilities.20,21
Similarly, severe acute respiratory syndrome (SARS)
and influenza A virus subtype H1N1 has been shown
to be transmitted by droplet nuclei generated by
patients. Environmental exposure to antibacterial
agents may also contribute to the development of
resistant organisms and hence increase the risk
of airborne infection.22-25 Due to the proximity
of acutely ill patients within the hospital, it is
reasonable to assume that pathogenic bacteria exist
in higher concentrations in the hospital environment
than in the home.
When aerosols containing
antibiotics settle on surfaces in the patient room and
vicinity, they may expose the ambient bacteria to
concentrations that are well below the level required
to kill the bacteria. Low concentration exposure to
antibiotics is associated with the development of
species that are resistant to that antibiotic.26
To the best of our knowledge, none have described
secondhand aerosol exposure during mechanical
ventilation although aerosols are commonly
administered to ventilator-dependent patients.
Commercial mechanical ventilators vary in their
approach to providing or recommending use of
filters in the expiratory limb of the ventilator
circuit. In many cases, such filters are required to
reduce the volume of drug depositing on sensors
and/or valves distal to the exhalation limb of the
678

ventilator circuit. Some ventilators are designed to
require the use of proprietary filters, while others
do not, but recommend their use.
For this paper the term proprietary filter is defined
as any filter required for use with a specific ventilator,
which cannot be readily substituted with any other
filter. They are typically larger, more complex highefficiency particulate air (HEPA) filters than other
simpler, low volume expiratory filters that may be
placed in the circuit. Despite its importance, there
have been no studies showing the effect of using
expiratory or proprietary filters on ventilator–
dependent patients on secondhand aerosol exposure
during mechanical ventilation. Therefore, the
objective of this study was to quantify the amount
of aerosol that exits from the ventilator exhaust
port under a variety of conditions ranging from no
filter, to the use of a filter placed in the circuit, to
the more sophisticated proprietary filters integral to
the ventilator.

Methods
Filtration and Ventilators: The types of filtration
that were tested with ventilators in this study were
divided into two categories: 1) Ventilators without
filters in the expiratory limb: The Servo-i (Maquet
Inc, Wayne, NJ) and the Galileo (Hamilton Medical,
Reno, NV), and (2) A ventilator with a proprietary
filter in the expiratory limb: PB 840 (CovidienNellcorTM and Puritan BennettTM, Boulder, CO).
Each ventilator was attached to a passive test lung
and operated in volume control ventilation with
adult parameters (VT 500 ml, RR 20 breaths/min,
PIF 50 L/min, and PEEP 5 cmH2O).
Experiments: As shown in Figure 1, in all
experiments, a collecting filter was placed distal to the
ventilator expiratory exhaust port. In Experiment A,
there was no filter at the end of the expiratory limb
with the aim of determining secondhand aerosol
exposure during mechanical ventilation without
expiratory filtration. In Experiment B, a filter
(Respirgard II, Vital Signs, Englewood, Colorado)
was placed in the expiratory limb proximal to the
ventilator to determine the effect of using a filter
at the end of the expiratory limb on secondhand
aerosol exposure during mechanical ventilation.
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Experiment A

Experiment B

Figure 1: Illustrations of the experimental set-ups used in Experiment A and Experiment B

Data collection: For each experiment, albuterol
(2.5 mg/3mL) was nebulised via a jet nebuliser
(eValueMed, Tri-anim) placed in the inspiratory
limb at the “Y” adaptor (n=3). The nebuliser was
operated continuously with 100% oxygen at 8 L/
min using a back pressure compensated flow meter
(Timemeter, St. Louis, MO). Nebulisation continued
until 1 minute past initiation of sputter. Drug was
eluted from the filters with 5 mL of 0.1 N HCl, with
agitation for 1 minute. Quantity of eluted drug was
determined by a UV spectrophotometer (Beckman
Coulter) at 276 nm.
Data analysis: The Statistical Package for Social
Science version 18 (SPSS Inc, Chicago, IL) was
used for the data analysis of this study. Using
descriptive statistics, secondhand aerosol exposure
was expressed as a mean (± SD) percentage of
the nominal dose placed in nebuliser. Independent
sample t-test and one way analysis of variance
(ANOVA) were conducted to compare the amount
of aerosol exiting from the exhaust port of each
ventilator. A p-value of less than 0.05 was considered
to be statistically significant.

Results
Table 1 shows the percent of nominal dose (mean
± standard deviation) delivered to the atmosphere

through the ventilators with or without expiratory
and proprietary filters.
Secondhand aerosol exposure without expiratory
and proprietary filters: The findings of this study
showed that drug deposited at the exhaust port of
the ventilator without expiratory and proprietary
filter ranged from 40% to 45% (Table 1).
The effect of proprietary filters on secondhand
aerosol exposure during mechanical ventilation:
In Experiment A, comparisons of drug deposited
at the exhaust filter revealed significant differences
between ventilators with and without proprietary
filters (p=0.0001). Drug deposited at the exhaust
port with proprietary filters was 0.25% in PB
840, which was 160 fold less than the ventilators
without proprietary filters. It was found that use
of proprietary filters with ventilators was the most
efficient way of preventing secondhand aerosol
exposure.
The effect of expiratory filters on secondhand
aerosol exposure during mechanical ventilation:
After the placement of expiratory filters on Servo-I
and Hamilton Galileo in Experiment B, comparisons
of drug deposition at the exhaust and expiratory
filters were repeated and a significant difference on

Table 1: Percent of nominal dose (mean ± standard deviation) delivered to the atmosphere through the ventilators with or without
expiratory and proprietary filters.
Ventilators without Proprietary Filters
Servo-i
Experiment A
Exhaust Filter only
40.6 ± 0.21%

Experiment B
Expiratory Filter
Exhaust Filter
39.9 ± 10.4%
2.2 ± 1.2%

Experiment A
Exhaust Filter only
45.1 ± 5.1%
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Hamilton Galileo
Experiment B
Expiratory Filter
Exhaust Filter
54.6 ± 5.3%
6.1 ± 0.7%

Ventilators with
Proprietary Filters
PB 840
Experiment A
Exhaust Filter only
0.25 ± 0.1%
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the exhaust filter (p=0.007) was found, while there
was no significant difference between drug deposited
on the expiratory filters of the Servo-i and the
Hamilton Galileo (p=0.09). As shown in Table 1,
placement of expiratory filters on the expiratory
limb of the ventilator circuit reduced secondhand
aerosol exposure during mechanical ventilation
by 94% in Servo–i and 88% in Hamilton Galileo
ventilators. Placement of a collecting filter at the
end of the expiratory limb decreased secondhand
aerosol exposure significantly both in Servo-i
and Hamilton Galileo (p=0.0001 and p=0.004,
respectively).

Discussion
The intent of our study was to quantify the amount
of aerosol that is released into the environment
from administration of bronchodilators through a
mechanical ventilator, and to determine the impact
of various forms of expiratory filtration. We found
that the amount of inhaled bronchodilator exiting
the ventilator ranged from 0.25% to 45% of a nominal
dose placed in the nebuliser depending on the type
of filters used during mechanical ventilation.
A standard small volume nebuliser operating
continuously
during
administration
of
bronchodilators in an ambulatory setting typically
has 0.8 – 1.2 mL of medication remaining in the
reservoir at the end of nebulisation. With a 3 mL
dose placed in the nebuliser, approximately 50 to 66%
of the nominal drug is emitted from the nebuliser as
aerosol. Consequently, the 45% of dose we measured
exiting the exhaust port of the ventilator represents
68 -90% of all aerosol entering the ventilator circuit,
identifying the ventilator as a rather efficient vehicle
for aerosol transmission into the atmosphere. Our
findings suggest that any aerosol emitted into the
ventilator circuit, whether from the nebuliser or the
patient’s airway might be expected to pass through
the ventilator circuit and exhaust port with similar
efficiency. At the time of this study, there were
no data identified in the literature investigating
secondhand aerosol exposure during mechanical
ventilation. Therefore, no comparison could be made
to the data collected in this study.
However, it is very well known that respiratory
therapists frequently administer aerosolised
680

medications, with continuous small volume nebulisers
which may spew 2/3s of the emitted aerosol into
the atmosphere. When a portion of the aerosolised
medication enters the atmosphere, it exposes those
individuals in the vicinity to inhalation of these
same medications along with the potential inhalation
of aerosolised organisms from the patients’ airways
and lungs.27 Those who inhaled aerosol particles
might be at risk of exposure for unwanted side
effects. To verify that health care workers do, in
fact, inhale portions of the medication exhaust,
Carnathan et al reported that respiratory therapists
have traces of inhaled medication in their plasma
when exposed to aerosolised racemic S & R isomers
of albuterol.16 In a study by Shults et al, nurses and
respiratory therapists were found to have ribavirin
in their urine when they were exposed to patients
receiving ribavirin treatments.28 Although none of
these studies have been conducted on health-care
professionals taking care of ventilator-dependent
patients, they all show that secondhand aerosol
exposure and uptake may result in some side effects
on individuals inhaling aerosolised medications.
According to the findings of this study, using
expiratory filters during mechanical ventilation
decreases the risk of exposure to aerosol released
to atmosphere from the ventilator. The proprietary
filter tested was the most efficient option, with only
0.25% of dose escaping the exhaust port. The other
filter options allowed 8 – 24 fold more aerosols
to pass through the exhaust into the ambient
environment. This difference could prove to be a
critical difference with transmission of infectious
droplet nuclei entering into the ICU or any acute
care facility. The case could be made that the higher
level of filtration efficiency should be considered the
safer standard than use of the less complex filters.
Another aspect of filter design is the amount of
time that a filter can efficiently remove aerosols from
gas prior to increasing resistance to flow of that
gas. The greater the surface area of the filtration
elements the longer they can collect material prior
to increase in resistance. Simple filters have less
internal area and may have increased resistance in a
shorter period. The difference in time to increased
resistance may range from hours to days. Changes
in expiratory resistance in the ventilator circuit can
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impact pressures and work of breathing. Filters
should be selected which have the least impact in
terms of both time of use before resistance changes,
and the degree of resistance changes that occur.
Evaluation of these parameters is beyond the limits
of this study. Therefore, future research on a broad
scale is needed in order to understand clinical and
environmental effects of second-hand aerosol
exposure during mechanical ventilation.
In conclusion, respiratory therapists, nurses, health
care workers, patients and families are exposed
to a variety of infectious agents and aerosolised
medications in the health care environment. As
long as second-hand aerosol exposure continues to
be a problem, health care professionals should be
able to protect themselves from possible side effects
of second-hand aerosol exposure while caring
for patient’s respiratory needs. The results of
our finding suggest that aerosol generated during
mechanical ventilation can readily be transmitted to
the ambient environment, and that simple measures
such as use of filters in the expiratory limb can
greatly reduce risk of second-hand aerosol exposure.
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